OVERALL SURVIVAL RESULTS FROM ARIEL3: A PHASE 3 RANDOMIZED, DOUBLE-BLIND STUDY OF RUCAPARIB VS PLACEBO FOLLOWING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR RECURRENT OVARIAN CARCINOMA

Overview

cited authors

Coleman, Robert L.; Oza, Amit; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne; Clamp, Andrew; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert; Amenedo Gancedo, Margarita; Fong, Peter; Goh, Jeffrey; O'Malley, David; Goble, Sandra; Maloney, Lara; Ledermann, Jonathan

authors

Holloway, Robert W., MD

Publication Date

December 1, 2022

webpage

Web of Science

published in

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Journal

Additional Document Info

start page

end page

volume

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.